{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36149902", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "28"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "23"}], "Language": ["eng"], "ELocationID": ["e0272362", "10.1371/journal.pone.0272362"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "17", "Issue": "9", "PubDate": {"Year": "2022"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway.", "Pagination": {"StartPage": "e0272362", "MedlinePgn": "e0272362"}, "Abstract": {"AbstractText": ["We report herein, the design and synthesis of thiazolidine-2,4-diones derivatives as new inhibitors for VEGFR-2. The designed members were assessed for their in vitro anticancer activity against four cancer cell lines; A549, Caco-2, HepG-2 and MDA-MB-231. Compound 14a showed the most potent effects against Caco-2, and HepG-2 cell lines (IC50 = of 1.5 and 31.5 \u03bcM, respectively). Next, the in vitro VEGFR-2 inhibitory activity, safety profiles and selectivity indices were examined for all the synthesized members against the normal Vero cell line. Compound 14a (the safest member against Caco-2 cell line) was further investigated for its ability to inhibit Caco-2 cells migration and healing. Moreover, the apoptotic induction of compound 14a against Caco-2 cell line was investigated by assessing against four apoptotic genes (Bcl2, Bcl-xl, TGF, and Survivin). The results revealed that compound 14a can exert apoptosis through significant reduction of Bcl2, Survivin, and TGF gene expression levels. Finally, deep computational studies including molecular docking, ADMET, toxicity studies, and MD simulation were carried out. Also, the DFT calculations were performed and discussed, and the results confirmed the inhibitory reactivity of 14a against VEGFR-2. Compound 14a is expected to be used as a potential lead in the development of new VEGFR-2 inhibitors with increased potency."]}, "AuthorList": [{"Identifier": ["0000-0003-0630-709X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Taghour", "ForeName": "Mohammed S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Elkady", "ForeName": "Hazem", "Initials": "H"}, {"Identifier": ["0000-0001-6996-4017"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh, Egypt."}], "LastName": "Eldehna", "ForeName": "Wagdy M", "Initials": "WM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}, {"Identifier": [], "Affiliation": "Pharmaceutical and Fermentation Industries Development Center, City of Scientific Research and Technological Applications (SRTA City), Alexandria, Egypt."}], "LastName": "El-Deeb", "ForeName": "Nehal", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Nucleic Acids Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}], "LastName": "Kenawy", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Bshra A", "Initials": "BA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Alesawy", "ForeName": "Mohamed S", "Initials": "MS"}, {"Identifier": ["0000-0001-7552-0914"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, New Valley University, El-Kharja, Egypt."}], "LastName": "Husein", "ForeName": "Dalal Z", "Initials": "DZ"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical and Fermentation Industries Development Center, City of Scientific Research and Technological Applications (SRTA City), Alexandria, Egypt."}, {"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Proto-Oncogene Proteins c-bcl-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Survivin"}, {"RegistryNumber": "0", "NameOfSubstance": "Thiazolidines"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Vascular Endothelial Growth Factor Receptor-2"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Caco-2 Cells"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-bcl-2"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["metabolism"], "DescriptorName": "Survivin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Thiazolidines"}, {"QualifierName": ["metabolism"], "DescriptorName": "Vascular Endothelial Growth Factor Receptor-2"}], "CoiStatement": "the authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "El-Dash Y., Elzayat E., Abdou A.M., Hassan R.A., Novel thienopyrimidine-aminothiazole hybrids: design, synthesis, antimicrobial screening, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and VEGFR-2 inhibition, Bioorganic Chemistry 114 (2021) 105137. doi: 10.1016/j.bioorg.2021.105137", "ArticleIdList": ["10.1016/j.bioorg.2021.105137", "34237644"]}, {"Citation": "Mahdy H.A., Ibrahim M.K., Metwaly A.M., Belal A., Mehany A.B., El-Gamal K.M., et al., Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers, Bioorganic Chemistry 94 (2020) 103422. doi: 10.1016/j.bioorg.2019.103422", "ArticleIdList": ["10.1016/j.bioorg.2019.103422", "31812261"]}, {"Citation": "El-Adl K., El-Helby A.-G.A., Sakr H., Eissa I.H., El-Hddad S.S., Shoman F.M., Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme, Bioorganic Chemistry (2020) 104059. doi: 10.1016/j.bioorg.2020.104059", "ArticleIdList": ["10.1016/j.bioorg.2020.104059", "32653608"]}, {"Citation": "Olsson A.-K., Dimberg A., Kreuger J., Claesson-Welsh L., VEGF receptor signalling? In control of vascular function, Nature reviews Molecular cell biology 7(5) (2006) 359\u2013371. doi: 10.1038/nrm1911", "ArticleIdList": ["10.1038/nrm1911", "16633338"]}, {"Citation": "Niu G., Chen X., Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy, Current drug targets 11(8) (2010) 1000\u20131017. doi: 10.2174/138945010791591395", "ArticleIdList": ["10.2174/138945010791591395", "PMC3617502", "20426765"]}, {"Citation": "Shibuya M., Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti-and pro-angiogenic therapies, Genes & cancer 2(12) (2011) 1097\u20131105.", "ArticleIdList": ["PMC3411125", "22866201"]}, {"Citation": "Elrazaz E.Z., Serya R.A., Ismail N.S., Albohy A., Abou El Ella D.A., Abouzid K.A., Discovery of Potent Thieno [2, 3-d] pyrimidine VEGFR-2 Inhibitors: Design, Synthesis and Enzyme Inhibitory Evaluation Supported by Molecular Dynamics Simulations, Bioorganic Chemistry (2021) 105019. doi: 10.1016/j.bioorg.2021.105019", "ArticleIdList": ["10.1016/j.bioorg.2021.105019", "34091286"]}, {"Citation": "Lee K., Jeong K.-W., Lee Y., Song J.Y., Kim M.S., Lee G.S., et al., Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors, European journal of medicinal chemistry 45(11) (2010) 5420\u20135427. doi: 10.1016/j.ejmech.2010.09.002", "ArticleIdList": ["10.1016/j.ejmech.2010.09.002", "20869793"]}, {"Citation": "Machado V.A., Peixoto D., Costa R., Froufe H.J., Calhelha R.C., Abreu R.M., et al., Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno [3, 2-b] pyridin-7-ylthio) phenyl] ureas: Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors, Biorg. Med. Chem. 23(19) (2015) 6497\u20136509. doi: 10.1016/j.bmc.2015.08.010", "ArticleIdList": ["10.1016/j.bmc.2015.08.010", "26344591"]}, {"Citation": "Garofalo A., Goossens L., Six P., Lemoine A., Ravez S., Farce A., et al., Impact of aryloxy-linked quinazolines: A novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors, Bioorg. Med. Chem. Lett. 21(7) (2011) 2106\u20132112. doi: 10.1016/j.bmcl.2011.01.137", "ArticleIdList": ["10.1016/j.bmcl.2011.01.137", "21353546"]}, {"Citation": "Marrone T.J., Briggs a., James M J.A. McCammon, Structure-based drug design: computational advances, Annual review of pharmacology and toxicology 37(1) (1997) 71\u201390.", "ArticleIdList": ["9131247"]}, {"Citation": "Li N., Wang Y., Li W., Li H., Yang L., Wang J., et al., Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer\u2019s Agents Targeting BACE1 and PPAR\u03b3, Journal of Chemistry 2020. (2020)."}, {"Citation": "Abdel-Aziz H.A., Eldehna W.M., Fares M., Al-Rashood S.T., Al-Rashood K.A., Abdel-Aziz M.M., et al., Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents, International journal of molecular sciences 16(4) (2015) 8719\u20138743. doi: 10.3390/ijms16048719", "ArticleIdList": ["10.3390/ijms16048719", "PMC4425105", "25903147"]}, {"Citation": "Akram M., Lal H., Shakya S., Varshney R., Molecular engineering of complexation between RNA and biodegradable cationic gemini surfactants: role of the hydrophobic chain length, Molecular Systems Design & Engineering (2022)."}, {"Citation": "Hasan A.H., Murugesan S., Amran S.I., Chander S., Alanazi M.M., Hadda T.B., et al., Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation, Bioorganic Chemistry 119 (2022) 105572. doi: 10.1016/j.bioorg.2021.105572", "ArticleIdList": ["10.1016/j.bioorg.2021.105572", "34971946"]}, {"Citation": "Alhomrani M., Alsanie W.F., Alamri A.S., Alyami H., Habeeballah H., Alkhatabi H.A., et al., Enhancing the Antipsychotic Effect of Risperidone by Increasing Its Binding Affinity to Serotonin Receptor via Picric Acid: A Molecular Dynamics Simulation, Pharmaceuticals 15(3) (2022) 285. doi: 10.3390/ph15030285", "ArticleIdList": ["10.3390/ph15030285", "PMC8952232", "35337083"]}, {"Citation": "Abbass E.M., Khalil A.K., Mohamed M.M., Eissa I.H., A.M.J.B.c. El-Naggar, Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers, 104 (2020) 104255.", "ArticleIdList": ["32927130"]}, {"Citation": "El-Adl K., Ibrahim M.-K., Alesawy M.S., Eissa I.H.J.B., Chemistry M., [1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4, 3-a: 4\u2032, 3\u2032-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies, 30 (2021) 115958. doi: 10.1016/j.bmc.2020.115958", "ArticleIdList": ["10.1016/j.bmc.2020.115958", "33360576"]}, {"Citation": "Hagras M., El Deeb M.A., Elzahabi H.S., Elkaeed E.B., Mehany A.B., Eissa I.H.J.J.o.e.i., m. chemistry, Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation, 36(1) (2021) 640\u2013658.", "ArticleIdList": ["PMC7889231", "33588683"]}, {"Citation": "Eissa I.H., Dahab M.A., Ibrahim M.K., Alsaif N.A., Alanazi A., Eissa S.I., et al., Design and discovery of new antiproliferative 1, 2, 4-triazin-3 (2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site, 112 (2021) 104965. doi: 10.1016/j.bioorg.2021.104965", "ArticleIdList": ["10.1016/j.bioorg.2021.104965", "34020238"]}, {"Citation": "El-Metwally S.A., Abou-El-Regal M.M., Eissa I.H., Mehany A.B., Mahdy H.A., Elkady H., et al., Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents, 112 (2021) 104947. doi: 10.1016/j.bioorg.2021.104947", "ArticleIdList": ["10.1016/j.bioorg.2021.104947", "33964580"]}, {"Citation": "El-Adl K., Sakr H.M., Yousef R.G., Mehany A.B., Metwaly A.M., Elhendawy M.A., et al., Discovery of new quinoxaline-2 (1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation, 114 (2021) 105105. doi: 10.1016/j.bioorg.2021.105105", "ArticleIdList": ["10.1016/j.bioorg.2021.105105", "34175720"]}, {"Citation": "Parmar D.R., Soni J.Y., Guduru R., Rayani R.H., Kusurkar R.V., Vala A.G., et al., Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies, 115 (2021) 105206.", "ArticleIdList": ["34339975"]}, {"Citation": "Alanazi M.M., Eissa I.H., Alsaif N.A., Obaidullah A.J., Alanazi W.A., Alasmari A.F., et al., Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers, Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1) (2021) 1760\u20131782. doi: 10.1080/14756366.2021.1956488", "ArticleIdList": ["10.1080/14756366.2021.1956488", "PMC8344243", "34340610"]}, {"Citation": "Yousef R.G., Sakr H.M., Eissa I.H., Mehany A.B., Metwaly A.M., Elhendawy M.A., et al., New quinoxaline-2 (1 H)-ones as potential VEGFR-2 inhibitors: design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations, 45(36) (2021) 16949\u201316964.", "ArticleIdList": ["34175720"]}, {"Citation": "Alanazi M.M., Elwan A., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., et al M. Chemistry, Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: Design, synthesis, and in silico studies, 36(1) (2021) 1732\u20131750.", "ArticleIdList": ["PMC8330740", "34325596"]}, {"Citation": "Ran F., Li W., Qin Y., Yu T., Liu Z., Zhou M., et al., c. longevity, Inhibition of vascular smooth muscle and cancer cell proliferation by new VEGFR inhibitors and their immunomodulator effect: design, synthesis, and biological evaluation, 2021. (2021).", "ArticleIdList": ["PMC8568530", "34745424"]}, {"Citation": "Elkady H., Elwan A., El-Mahdy H.A., Doghish A.S., Ismail A., Taghour M.S., et al., m. chemistry, New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies, 37(1) (2022) 397\u2013410.", "ArticleIdList": ["PMC8725875", "34961427"]}, {"Citation": "Meth-Cohn O., Narine B., Tarnowski B., A versatile new synthesis of quinolines and related fused pyridines. Part II, Tetrahedron Letters 20(33) (1979) 3111\u20133114."}, {"Citation": "Kar K., Krithika U., Basu P., Kumar S.S., Reji A., Kumar B.P., Design, synthesis and glucose uptake activity of some novel glitazones, Bioorganic chemistry 56 (2014) 27\u201333. doi: 10.1016/j.bioorg.2014.05.006", "ArticleIdList": ["10.1016/j.bioorg.2014.05.006", "24927033"]}, {"Citation": "Abdel-Wahab B.F., Khidre R.E., 2-Chloroquinoline-3-carbaldehyde II: synthesis, reactions, and applications, Journal of Chemistry 2013 (2013)."}, {"Citation": "Yu Y.-C., Kuang W.-B., Huang R.-Z., Fang Y.-L., Zhang Y., Chen Z.-F., et al., Design, synthesis and pharmacological evaluation of new 2-oxo-quinoline derivatives containing \u03b1-aminophosphonates as potential antitumor agents, MedChemComm 8(6) (2017) 1158\u20131172. doi: 10.1039/c7md00098g", "ArticleIdList": ["10.1039/c7md00098g", "PMC6072518", "30108826"]}, {"Citation": "Bruno G., Costantino L., Curinga C., Maccari R., Monforte F., Nicolo F., et al., Synthesis and aldose reductase inhibitory activity of 5-arylidene-2, 4-thiazolidinediones, Bioorganic & medicinal chemistry 10(4) (2002) 1077\u20131084. doi: 10.1016/s0968-0896(01)00366-2", "ArticleIdList": ["10.1016/s0968-0896(01)00366-2", "11836118"]}, {"Citation": "Evdokimov N.M., Magedov I.V., McBrayer D., Kornienko A., Isatin derivatives with activity against apoptosis-resistant cancer cells, Bioorganic & medicinal chemistry letters 26(6) (2016) 1558\u20131560. doi: 10.1016/j.bmcl.2016.02.015", "ArticleIdList": ["10.1016/j.bmcl.2016.02.015", "PMC4775416", "26883150"]}, {"Citation": "Datar P.A., Aher S.B., Design and synthesis of novel thiazolidine-2, 4-diones as hypoglycemic agents, Journal of Saudi Chemical Society 20 (2016) S196\u2013S201."}, {"Citation": "Pritchett J.C., Naesens L., Montoya J., Treating HHV-6 infections: The laboratory efficacy and clinical use of ati-HHV-6 agents, (2014)."}, {"Citation": "Pe\u00f1a-Mor\u00e1n O.A., Villarreal M.L., \u00c1lvarez-Berber L., Meneses-Acosta A., Rodr\u00edguez-L\u00f3pez V.J.M., Cytotoxicity, post-treatment recovery, and selectivity analysis of naturally occurring podophyllotoxins from Bursera fagaroides var. fagaroides on breast cancer cell lines, 21(8) (2016) 1013.", "ArticleIdList": ["PMC6274026", "27527135"]}, {"Citation": "Liang C.-C., Park A.Y., Guan J.-L., In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro, Nature protocols 2(2) (2007) 329\u2013333. doi: 10.1038/nprot.2007.30", "ArticleIdList": ["10.1038/nprot.2007.30", "17406593"]}, {"Citation": "Yang J., Song K., Krebs T.L., Jackson M.W., Danielpour D., Rb/E2F4 and Smad2/3 link survivin to TGF-\u03b2-induced apoptosis and tumor progression, Oncogene 27(40) (2008) 5326\u20135338.", "ArticleIdList": ["PMC2762862", "18504435"]}, {"Citation": "Kim R., Unknotting the roles of Bcl-2 and Bcl-xL in cell death, Biochemical and biophysical research communications 333(2) (2005) 336\u2013343. doi: 10.1016/j.bbrc.2005.04.161", "ArticleIdList": ["10.1016/j.bbrc.2005.04.161", "15922292"]}, {"Citation": "El-Helby A.-G.A., Ayyad R.R., El-Adl K., Elkady H., Phthalazine-1, 4-dione derivatives as non-competitive AMPA receptor antagonists: design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking, Molecular diversity 23(2) (2019) 283\u2013298. doi: 10.1007/s11030-018-9871-y", "ArticleIdList": ["10.1007/s11030-018-9871-y", "30168051"]}, {"Citation": "El\u2010Helby A.G.A., Ayyad R.R., Zayed M.F., Abulkhair H.S., Elkady H., El\u2010Adl K., Design, synthesis, in silico ADMET profile and GABA\u2010A docking of novel phthalazines as potent anticonvulsants, Archiv Der Pharmazie 352(5) (2019) 1800387. doi: 10.1002/ardp.201800387", "ArticleIdList": ["10.1002/ardp.201800387", "30989729"]}, {"Citation": "Abdallah A.E., Alesawy M.S., Eissa S.I., El-Fakharany E.M., Kalaba M.H., Sharaf M.H., et al., Design and synthesis of new 4-(2-nitrophenoxy) benzamide derivatives as potential antiviral agents: Molecular modeling and in vitro antiviral screening, New Journal of Chemistry 45(36) (2021) 16557\u201316571."}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D., Classification of kinase inhibitors using a Bayesian model, Journal of medicinal chemistry 47(18) (2004) 4463\u20134470. doi: 10.1021/jm0303195", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA, QSAR, ADMET and Predictive Toxicology. https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html. (Accessed May 2020."}, {"Citation": "Sousa S.F., Fernandes P.A., Ramos M.J., Protein\u2013ligand docking: current status and future challenges, Proteins: Structure, Function, and Bioinformatics 65(1) (2006) 15\u201326.", "ArticleIdList": ["16862531"]}, {"Citation": "Hollingsworth S.A., Dror R.O., Molecular dynamics simulation for all, Neuron 99(6) (2018) 1129\u20131143. doi: 10.1016/j.neuron.2018.08.011", "ArticleIdList": ["10.1016/j.neuron.2018.08.011", "PMC6209097", "30236283"]}, {"Citation": "Hansson T., Oostenbrink C., van Gunsteren W., Molecular dynamics simulations, Current opinion in structural biology 12(2) (2002) 190\u2013196. doi: 10.1016/s0959-440x(02)00308-1", "ArticleIdList": ["10.1016/s0959-440x(02)00308-1", "11959496"]}, {"Citation": "Durrant J.D., McCammon J.A., Molecular dynamics simulations and drug discovery, BMC biology 9(1) (2011) 1\u20139. doi: 10.1186/1741-7007-9-71", "ArticleIdList": ["10.1186/1741-7007-9-71", "PMC3203851", "22035460"]}, {"Citation": "Wang T., Husein D.Z., Novel synthesis of multicomponent porous nano-hybrid composite, theoretical investigation using DFT and dye adsorption applications: disposing of waste with waste, Environmental Science and Pollution Research (2022) 1\u201328.", "ArticleIdList": ["35460480"]}, {"Citation": "Husein D.Z., Hassanien R., Khamis M., Cadmium oxide nanoparticles/graphene composite: synthesis, theoretical insights into reactivity and adsorption study, RSC Advances 11(43) (2021) 27027\u201327041. doi: 10.1039/d1ra04754j", "ArticleIdList": ["10.1039/d1ra04754j", "PMC9037664", "35480026"]}, {"Citation": "Thabrew M.I., Hughes R.D., McFarlane I.G., Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay, Journal of pharmacy and pharmacology 49(11) (1997) 1132\u20131135. doi: 10.1111/j.2042-7158.1997.tb06055.x", "ArticleIdList": ["10.1111/j.2042-7158.1997.tb06055.x", "9401951"]}, {"Citation": "El-Deeb N.M., Ibrahim O.M., Mohamed M.A., Farag M.M., Farrag A.A., El-Aassar M., Alginate/\u03ba-carrageenan oral microcapsules loaded with Agaricus bisporus polysaccharides MH751906 for natural killer cells mediated colon cancer immunotherapy, International Journal of Biological Macromolecules (2022). doi: 10.1016/j.ijbiomac.2022.02.058", "ArticleIdList": ["10.1016/j.ijbiomac.2022.02.058", "35183600"]}, {"Citation": "El-Zahabi M.A., Sakr H., El-Adl K., Zayed M., Abdelraheem A.S., Eissa S.I., et al., Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents, Bioorganic chemistry 104 (2020) 104218. doi: 10.1016/j.bioorg.2020.104218", "ArticleIdList": ["10.1016/j.bioorg.2020.104218", "32932121"]}, {"Citation": "Abou-Seri S.M., Eldehna W.M., Ali M.M., Abou El Ella D.A., 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: synthesis and in vitro biological evaluation, European journal of medicinal chemistry 107 (2016) 165\u2013179. doi: 10.1016/j.ejmech.2015.10.053", "ArticleIdList": ["10.1016/j.ejmech.2015.10.053", "26590508"]}, {"Citation": "Alsaif N.A., Taghour M.S., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., et al., Discovery of new VEGFR-2 inhibitors based on bis ([1, 2,4 ] triazolo)[4, 3-a: 3\u2019, 4\u2019-c] quinoxaline derivatives as anticancer agents and apoptosis inducers, Journal of enzyme inhibition and medicinal chemistry 36(1) (2021) 1093\u20131114. doi: 10.1080/14756366.2021.1915303", "ArticleIdList": ["10.1080/14756366.2021.1915303", "PMC8168755", "34056992"]}, {"Citation": "Borenfreund E., Puerner J.A., Toxicity determined in vitro by morphological alterations and neutral red absorption, Toxicology letters 24(2\u20133) (1985) 119\u2013124. doi: 10.1016/0378-4274(85)90046-3", "ArticleIdList": ["10.1016/0378-4274(85)90046-3", "3983963"]}, {"Citation": "Koch A., Tamez P., Pezzuto J., Soejarto D., Evaluation of plants used for antimalarial treatment by the Maasai of Kenya, Journal of Ethnopharmacology 101(1\u20133) (2005) 95\u201399. doi: 10.1016/j.jep.2005.03.011", "ArticleIdList": ["10.1016/j.jep.2005.03.011", "15878245"]}, {"Citation": "Arranz-Valsero I., Soriano-Roman\u00ed L., Garc\u00eda-Posadas L., L\u00f3pez-Garc\u00eda A., Diebold Y., IL-6 as a corneal wound healing mediator in an in vitro scratch assay, Experimental Eye Research 125 (2014) 183\u2013192. doi: 10.1016/j.exer.2014.06.012", "ArticleIdList": ["10.1016/j.exer.2014.06.012", "24971496"]}, {"Citation": "Zucchini N., de Sousa G., Bailly-Maitre B., Gugenheim J., Bars R., Lemaire G., et al., Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes, Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1745(1) (2005) 48\u201358. doi: 10.1016/j.bbamcr.2005.02.005", "ArticleIdList": ["10.1016/j.bbamcr.2005.02.005", "16085054"]}, {"Citation": "El-Zahabi M.A., Elbendary E.R., Bamanie F.H., Radwan M.F., Ghareib S.A., Eissa I.H., Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPAR\u03b3 and SUR agonists, Bioorg. Chem. 91 (2019) 103115. doi: 10.1016/j.bioorg.2019.103115", "ArticleIdList": ["10.1016/j.bioorg.2019.103115", "31310882"]}, {"Citation": "Ibrahim M.K., Eissa I.H., Alesawy M.S., Metwaly A.M., Radwan M.M., ElSohly M.A., Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPAR\u03b3 and SUR agonists, Bioorganic & medicinal chemistry 25(17) (2017) 4723\u20134744.", "ArticleIdList": ["28720328"]}, {"Citation": "Ibrahim M.K., Eissa I.H., Abdallah A.E., Metwaly A.M., Radwan M., ElSohly M., Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPAR\u03b3 and SUR agonists, Biorg. Med. Chem. 25(4) (2017) 1496\u20131513.", "ArticleIdList": ["28117121"]}, {"Citation": "El-Gamal K.M., El-Morsy A.M., Saad A.M., Eissa I.H., Alswah M., Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors, Journal of Molecular Structure 1166 (2018) 15\u201333."}, {"Citation": "Elkaeed E.B., Elkady H., Belal A., Alsfouk B.A., Ibrahim T.H., Abdelmoaty M., et al., Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs, Processes 10(3) (2022) 530."}, {"Citation": "Suleimen Y.M., Jose R.A., Suleimen R.N., Arenz C., Ishmuratova M.Y., Toppet S., et al., a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease, Molecules 27(5) (2022) 1636.", "ArticleIdList": ["PMC8911936", "35268738"]}, {"Citation": "Suleimen Y.M., Jose R.A., Suleimen R.N., Arenz C., Ishmuratova M., Toppet S., et al., Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from Artemisia spp, Molecules 27(4) (2022) 1216. doi: 10.3390/molecules27041216", "ArticleIdList": ["10.3390/molecules27041216", "PMC8879996", "35209006"]}, {"Citation": "Alanazi M.M., Elkady H., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Alanazi M.M., et al., New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies, RSC Advances 11(48) (2021) 30315\u201330328. doi: 10.1039/d1ra05925d", "ArticleIdList": ["10.1039/d1ra05925d", "PMC9044819", "35493991"]}, {"Citation": "Alsaif N.A., Dahab M.A., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., et al., New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: design, molecular modeling, and synthesis, Bioorganic Chemistry 110 (2021) 104807. doi: 10.1016/j.bioorg.2021.104807", "ArticleIdList": ["10.1016/j.bioorg.2021.104807", "33721808"]}, {"Citation": "Mohammed S.O., El Ashry E.S.H., Khalid A., Amer M.R., Metwaly A.M., Eissa I.H., et al., Expression, Purification, and Comparative Inhibition of Helicobacter pylori Urease by Regio-Selectively Alkylated Benzimidazole 2-Thione Derivatives, Molecules 27(3) (2022) 865. doi: 10.3390/molecules27030865", "ArticleIdList": ["10.3390/molecules27030865", "PMC8838460", "35164122"]}, {"Citation": "Alesawy M.S., Elkaeed E.B., Alsfouk A.A., Metwaly A.M., Eissa I., In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies, Molecules 26(21) (2021) 6593. doi: 10.3390/molecules26216593", "ArticleIdList": ["10.3390/molecules26216593", "PMC8588135", "34771004"]}, {"Citation": "Alanazi M.M., Elkady H., Alsaif N.A., Obaidullah A.J., Alanazi W.A., Al-Hossaini A.M., et al., Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study, Journal of Molecular Structure (2021) 132220."}, {"Citation": "Jo S., Kim T., Iyer V.G., Im W., CHARMM-GUI: A web-based graphical user interface for CHARMM, Journal of computational chemistry 29(11) (2008) 1859\u20131865. doi: 10.1002/jcc.20945", "ArticleIdList": ["10.1002/jcc.20945", "18351591"]}, {"Citation": "Brooks B.R., Brooks C.L. III, Mackerell A.D. Jr., Nilsson L., Petrella R.J., Roux B., et al., CHARMM: The biomolecular simulation program, Journal of computational chemistry 30(10) (2009) 1545\u20131614. doi: 10.1002/jcc.21287", "ArticleIdList": ["10.1002/jcc.21287", "PMC2810661", "19444816"]}, {"Citation": "Lee J., Cheng X., Swails J.M., Yeom M.S., Eastman P.K., Lemkul J.A., et al., Im, CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field, Journal of chemical theory and computation 12(1) (2016) 405\u2013413.", "ArticleIdList": ["PMC4712441", "26631602"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "4"}, {"Year": "2022", "Month": "7", "Day": "18"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "13", "Minute": "43"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["36149902", "PMC9506633", "10.1371/journal.pone.0272362", "PONE-D-22-13065"]}}], "PubmedBookArticle": []}